2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder CancerIntermediate Risk Non-Muscle Invasive Bladder CancerRecruitingPhase 32026-10-07NCT06510374
Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal PelvisLow-grade Upper Tract Urothelial CarcinomaRecruitingPhase 1 / Phase 22026-09-15NCT06668493